peptide-e-(adrenal-medulla) and ubenimex

peptide-e-(adrenal-medulla) has been researched along with ubenimex* in 1 studies

Other Studies

1 other study(ies) available for peptide-e-(adrenal-medulla) and ubenimex

Article	Year
Protease inhibition increases the analgesic potency of peptide E. Neuropharmacology, 1985, Volume: 24, Issue:2 Peptide E (PE), an opioid peptide from adrenal medulla, is known to possess very low analgesic potency when injected intracerebroventricularly in mice. The present study showed that PE analgesia was increased by co-injection with protease inhibitors (bacitracin and bestatin). Topics: Analgesics; Animals; Bacitracin; beta-Endorphin; Drug Synergism; Endorphins; Enkephalins; Injections, Intraventricular; Leucine; Male; Mice; Peptides; Protease Inhibitors	1985

Article

Year

Protease inhibition increases the analgesic potency of peptide E.

Neuropharmacology, 1985, Volume: 24, Issue:2

Peptide E (PE), an opioid peptide from adrenal medulla, is known to possess very low analgesic potency when injected intracerebroventricularly in mice. The present study showed that PE analgesia was increased by co-injection with protease inhibitors (bacitracin and bestatin).

Topics: Analgesics; Animals; Bacitracin; beta-Endorphin; Drug Synergism; Endorphins; Enkephalins; Injections, Intraventricular; Leucine; Male; Mice; Peptides; Protease Inhibitors

1985